Inj Ketamine 50mg per ml,Inj Morphine 15mg per ml,Inj Pentazocine 30mg per ml,Inj Phenytoin sodiam
Indian Army
EAST SIKKIM, SIKKIM
Bid Publish Date
11-Apr-2025, 3:29 pm
Bid End Date
02-Jun-2025, 3:00 pm
Location
Progress
RAQuantity
3151600
Bid Type
Two Packet Bid
N/a invites bids for Inj Adrenaline, Inj Amikacin, Inj Amphoteracin, Inj Aminophylline, Inj Artisunate 60 mg Vial, Inj Atracurium Besylate, Inj Atropine Sulphate, Inj Ampicillin 500 mg Vial, Inj Amoxy 1 gm with Clavulanic Acid, Inj Anti Rabies Vaccine, Inj Anti Tetanus Vaccine, Inj Amphoteracin B Lipid Complex, Inj Azithromycin 500 mg Vial, Inj Acyclovir 250 mg, Inj Acyclovir 500 mg, Inj Aztreonam 1 gm Vial, Inj Adenosine, Inj Amiodarone, Inj Ascorbic Acid, Inj Amphotericin, Inj Bupivacaine in Dextrose, Inj Bupivacaine, Inj Benzathine Penicillin, Inj Caspofungin 50 mg Vial, Inj Cefepime 1 gm Vial, Inj Cefoperazone 500 mg and Sulbactum 500mg, Inj Cefuroxime Sod. 750 mg Vial, Inj Clindamycin 600 mg per 4 ml Amp, Inj Ceftazidime 1 gm Vial, Inj Cefotaxime 1 gm, Inj Ceftriaxone 1 gm, Inj Calcium Gluconate 100 mg per ml, Inj Colistin Methanosulfonate 1 MIU, Inj Diltiazem 5 mg per ml, Inj Dexmedetomidine 200 mcgper 2 ml, Inj Digoxin 0. 25 mg per ml, Inj Dexamethasone 4 mg per 2 ml Vial, Inj Diazepam 5 mg per ml, Inj Diclofenac Sodium 25 mg per ml, Inj Diclofenac Sodium 75 mg per ml, Water for Injection 5 ml Amp, Inj Dopamine Hcl 40 mg per ml, Inj Doxycycline 100 mg Vial, Inj Etophylline 169 mg with Theophylline, Inj Ferric Carboxymaltose 500 mg per 10 ml Vial, Inj Esmolol 10 mg per ml Vial, Inj Enoxaparin 40 mg, Inj Enoxaparin 60 mg, Inj Frusemide 10 mg per ml, Inj Ganciclovir Lyophilised 500 mg Vial, Inj Gentamycin 80 mg per 2 ml, Inj Glycopyrrolate 0. 2 mg per ml, Inj Haloperidol 5 mg per ml, Inj Heparin 25000 IUper 5 ml, Inj Hydrocortisone 100 mg Vial, Inj Hyoscine Butyl Bromide 20 mg per ml, Inj Insulin Glargine 100 IUperml, Inj Insulin Mixtard, Inj Insulin NPH Lente, Inj Insulin Plain, Inj Imipenam 500 mg with Cilastatin 500 mg Vial, Inj Isoprenaline 2 mg per ml, Inj Ketamine, Inj L Ornithine L Aspartate, Inj Lignocaine 2 percent 50 ml, Inj Lignocaine 20 mg with Adrenaline, Inj Lignocaine Plain, Inj Labetalol 20 mg per 4 ml, Inj Levetiracetam 500 mlper 5 ml, Inj Methyl Prednisolone Acetate 500 mg Vial, Inj Methyl Prednisolone Acetate 1000 mg Vial, Inj Methyl Prednisolone 40 mg, Inj Metoprolol Tartrate 1 mg per ml, Inj Meropenam 1 gm Vial, Inj Magnessium Sulphate 500 mg per ml, Inj Mephentermine 30 mg per ml, Inj Metaclopramide 5 mg per ml, Inj Methyl Ergometrine, Inj Midazolam 5 mg per ml, Inj Multi Vitamin, In. Noradrenaline 4 mg per ml, Inj Neostigamine 0. 5 mg per ml, Inj Nitroglycerine 1 mg per ml, Inj Octreotide 50 mcg Amp, Inj Ondensterone 2 mg per ml, Inj Oxytocin 5 IUper ml, Inj Pantoprazole 40 mg per 10 ml, Inj Phenaramine Maleate, Inj Phenobarbitone 200 mg per ml, Inj Phenytoin Sodium 50 mg per ml, Inj Phenylephrine Hcl 10 mg per ml, Inj Pipracillin 4 gm with Tazobactum, Inj Potassium Chloride 150 mg per 10 ml, Inj Pralidoxime, Inj Promethazine Hcl 25 ml, Inj Propofol 1 percent, Inj Ranitidine 25 mg per ml, Inj Rocuronium Bromide 10 mg per ml, Inj Sodabicarb 7. 5 percent, Inj Sodium Valporate 100 mg per 5 ml, Inj Thiopentone Sodium 1 gm Vial, Inj Tiecoplanin 400 mg Vial, Inj Tiecoplanin 200 mg per 3 ml Vial, Inj Tigecycline 50 mg Vial, Inj Tranexanic Acid 100 mg per ml, Inj Thiamine 100 mg per 2 ml, Inj Vacuronium Bromide 4 mg per 2 ml, Inj Vasopressin 20 IU Amp. , Inj Vancomycin 500 mg Vial in CENTRAL DELHI, DELHI. Quantity: 3151600. Submission Deadline: 02-06-2025 15: 00: 00. Submit your proposal before the deadline.
Main Document
BOQ
BOQ
OTHER
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Indian Army
EAST SIKKIM, SIKKIM
Indian Army
POONCH, JAMMU & KASHMIR
Indian Army
LEH, JAMMU & KASHMIR
Indian Navy
MUMBAI, MAHARASHTRA
Indian Army
RAJAURI, JAMMU & KASHMIR
Tender Results
Loading results...
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) |
|---|---|---|---|---|---|---|
| 1 | Inj Adrenaline | as per specs | 70,000 | nos | 18manish | 365 |
| 2 | Inj Amikacin | as per specs | 50,000 | nos | 18manish | 365 |
| 3 | Inj Amphoteracin | as per specs | 10,000 | nos | 18manish | 365 |
| 4 | Inj Aminophylline | as per specs | 1,000 | nos | 18manish | 365 |
| 5 | Inj Artisunate 60 mg Vial | as per specs | 7,500 | nos | 18manish | 365 |
| 6 | Inj Atracurium Besylate | as per specs | 40,000 | nos | 18manish | 365 |
| 7 | Inj Atropine Sulphate | as per specs | 10,000 | nos | 18manish | 365 |
| 8 | Inj Ampicillin 500 mg Vial | as per specs | 2,000 | nos | 18manish | 365 |
| 9 | Inj Amoxy 1 gm with Clavulanic Acid | as per specs | 50,000 | nos | 18manish | 365 |
| 10 | Inj Anti Rabies Vaccine | as per specs | 10,000 | nos | 18manish | 365 |
| 11 | Inj Anti Tetanus Vaccine | as per specs | 40,000 | nos | 18manish | 365 |
| 12 | Inj Amphoteracin B Lipid Complex | as per specs | 400 | nos | 18manish | 365 |
| 13 | Inj Azithromycin 500 mg Vial | as per specs | 6,000 | nos | 18manish | 365 |
| 14 | Inj Acyclovir 250 mg | as per specs | 15,000 | nos | 18manish | 365 |
| 15 | Inj Acyclovir 500 mg | as per specs | 8,000 | nos | 18manish | 365 |
| 16 | Inj Aztreonam 1 gm Vial | as per specs | 2,000 | nos | 18manish | 365 |
| 17 | Inj Adenosine | as per specs | 2,300 | nos | 18manish | 365 |
| 18 | Inj Amiodarone | as per specs | 4,500 | nos | 18manish | 365 |
| 19 | Inj Ascorbic Acid | as per specs | 2,000 | nos | 18manish | 365 |
| 20 | Inj Amphotericin | as per specs | 400 | nos | 18manish | 365 |
| 21 | Inj Bupivacaine in Dextrose | as per specs | 3,000 | nos | 18manish | 365 |
| 22 | Inj Bupivacaine | as per specs | 3,500 | nos | 18manish | 365 |
| 23 | Inj Benzathine Penicillin | as per specs | 5,000 | nos | 18manish | 365 |
| 24 | Inj Caspofungin 50 mg Vial | as per specs | 2,400 | nos | 18manish | 365 |
| 25 | Inj Cefepime 1 gm Vial | as per specs | 300 | nos | 18manish | 365 |
| 26 | Inj Cefoperazone 500 mg and Sulbactum 500mg | as per specs | 2,000 | nos | 18manish | 365 |
| 27 | Inj Cefuroxime Sod. 750 mg Vial | as per specs | 3,000 | nos | 18manish | 365 |
| 28 | Inj Clindamycin 600 mg per 4 ml Amp | as per specs | 20,000 | nos | 18manish | 365 |
| 29 | Inj Ceftazidime 1 gm Vial | as per specs | 5,000 | nos | 18manish | 365 |
| 30 | Inj Cefotaxime 1 gm | as per specs | 20,000 | nos | 18manish | 365 |
| 31 | Inj Ceftriaxone 1 gm | as per specs | 250,000 | nos | 18manish | 365 |
| 32 | Inj Calcium Gluconate 100 mg per ml | as per specs | 50,000 | nos | 18manish | 365 |
| 33 | Inj Colistin Methanosulfonate 1 MIU | as per specs | 25,000 | nos | 18manish | 365 |
| 34 | Inj Diltiazem 5 mg per ml | as per specs | 500 | nos | 18manish | 365 |
| 35 | Inj Dexmedetomidine 200 mcgper 2 ml | as per specs | 3,000 | nos | 18manish | 365 |
| 36 | Inj Digoxin 0.25 mg per ml | as per specs | 200 | nos | 18manish | 365 |
| 37 | Inj Dexamethasone 4 mg per 2 ml Vial | as per specs | 35,000 | nos | 18manish | 365 |
| 38 | Inj Diazepam 5 mg per ml | as per specs | 1,000 | nos | 18manish | 365 |
| 39 | Inj Diclofenac Sodium 25 mg per ml | as per specs | 2,000 | nos | 18manish | 365 |
| 40 | Inj Diclofenac Sodium 75 mg per ml | as per specs | 140,000 | nos | 18manish | 365 |
| 41 | Water for Injection 5 ml Amp | as per specs | 2,000 | nos | 18manish | 365 |
| 42 | Inj Dopamine Hcl 40 mg per ml | as per specs | 1,000 | nos | 18manish | 365 |
| 43 | Inj Doxycycline 100 mg Vial | as per specs | 10,000 | nos | 18manish | 365 |
| 44 | Inj Etophylline 169 mg with Theophylline | as per specs | 11,000 | nos | 18manish | 365 |
| 45 | Inj Ferric Carboxymaltose 500 mg per 10 ml Vial | as per specs | 1,500 | nos | 18manish | 365 |
| 46 | Inj Esmolol 10 mg per ml Vial | as per specs | 1,500 | nos | 18manish | 365 |
| 47 | Inj Enoxaparin 40 mg | as per specs | 20,000 | nos | 18manish | 365 |
| 48 | Inj Enoxaparin 60 mg | as per specs | 40,000 | nos | 18manish | 365 |
| 49 | Inj Frusemide 10 mg per ml | as per specs | 120,000 | nos | 18manish | 365 |
| 50 | Inj Ganciclovir Lyophilised 500 mg Vial | as per specs | 500 | nos | 18manish | 365 |
| 51 | Inj Gentamycin 80 mg per 2 ml | as per specs | 5,000 | nos | 18manish | 365 |
| 52 | Inj Glycopyrrolate 0.2 mg per ml | as per specs | 35,000 | nos | 18manish | 365 |
| 53 | Inj Haloperidol 5 mg per ml | as per specs | 500 | nos | 18manish | 365 |
| 54 | Inj Heparin 25000 IUper 5 ml | as per specs | 20,000 | nos | 18manish | 365 |
| 55 | Inj Hydrocortisone 100 mg Vial | as per specs | 30,000 | nos | 18manish | 365 |
| 56 | Inj Hyoscine Butyl Bromide 20 mg per ml | as per specs | 25,000 | nos | 18manish | 365 |
| 57 | Inj Insulin Glargine 100 IUperml | as per specs | 5,000 | nos | 18manish | 365 |
| 58 | Inj Insulin Mixtard | as per specs | 22,000 | nos | 18manish | 365 |
| 59 | Inj Insulin NPH Lente | as per specs | 3,500 | nos | 18manish | 365 |
| 60 | Inj Insulin Plain | as per specs | 9,000 | nos | 18manish | 365 |
| 61 | Inj Imipenam 500 mg with Cilastatin 500 mg Vial | as per specs | 700 | nos | 18manish | 365 |
| 62 | Inj Isoprenaline 2 mg per ml | as per specs | 200 | nos | 18manish | 365 |
| 63 | Inj Ketamine | as per specs | 2,400 | nos | 18manish | 365 |
| 64 | Inj L Ornithine L Aspartate | as per specs | 1,000 | nos | 18manish | 365 |
| 65 | Inj Lignocaine 2 percent 50 ml | as per specs | 3,000 | nos | 18manish | 365 |
| 66 | Inj Lignocaine 20 mg with Adrenaline | as per specs | 4,000 | nos | 18manish | 365 |
| 67 | Inj Lignocaine Plain | as per specs | 13,000 | nos | 18manish | 365 |
| 68 | Inj Labetalol 20 mg per 4 ml | as per specs | 15,000 | nos | 18manish | 365 |
| 69 | Inj Levetiracetam 500 mlper 5 ml | as per specs | 50,000 | nos | 18manish | 365 |
| 70 | Inj Methyl Prednisolone Acetate 500 mg Vial | as per specs | 2,000 | nos | 18manish | 365 |
| 71 | Inj Methyl Prednisolone Acetate 1000 mg Vial | as per specs | 1,000 | nos | 18manish | 365 |
| 72 | Inj Methyl Prednisolone 40 mg | as per specs | 500 | nos | 18manish | 365 |
| 73 | Inj Metoprolol Tartrate 1 mg per ml | as per specs | 1,000 | nos | 18manish | 365 |
| 74 | Inj Meropenam 1 gm Vial | as per specs | 75,000 | nos | 18manish | 365 |
| 75 | Inj Magnessium Sulphate 500 mg per ml | as per specs | 50,000 | nos | 18manish | 365 |
| 76 | Inj Magnessium Sulphate 500 mg per ml | as per specs | 5,000 | nos | 18manish | 365 |
| 77 | Inj Mephentermine 30 mg per ml | as per specs | 1,200 | nos | 18manish | 365 |
| 78 | Inj Metaclopramide 5 mg per ml | as per specs | 45,000 | nos | 18manish | 365 |
| 79 | Inj Methyl Ergometrine | as per specs | 500 | nos | 18manish | 365 |
| 80 | Inj Midazolam 5 mg per ml | as per specs | 120,000 | nos | 18manish | 365 |
| 81 | Inj Multi Vitamin | as per specs | 30,000 | nos | 18manish | 365 |
| 82 | In. Noradrenaline 4 mg per ml | as per specs | 140,000 | nos | 18manish | 365 |
| 83 | Inj Neostigamine 0.5 mg per ml | as per specs | 50,000 | nos | 18manish | 365 |
| 84 | Inj Nitroglycerine 1 mg per ml | as per specs | 5,000 | nos | 18manish | 365 |
| 85 | Inj Octreotide 50 mcg Amp | as per specs | 32,000 | nos | 18manish | 365 |
| 86 | Inj Ondensterone 2 mg per ml | as per specs | 225,000 | nos | 18manish | 365 |
| 87 | Inj Oxytocin 5 IUper ml | as per specs | 22,000 | nos | 18manish | 365 |
| 88 | Inj Pantoprazole 40 mg per 10 ml | as per specs | 350,000 | nos | 18manish | 365 |
| 89 | Inj Phenaramine Maleate | as per specs | 16,000 | nos | 18manish | 365 |
| 90 | Inj Phenobarbitone 200 mg per ml | as per specs | 1,000 | nos | 18manish | 365 |
| 91 | Inj Phenytoin Sodium 50 mg per ml | as per specs | 30,000 | nos | 18manish | 365 |
| 92 | Inj Phenylephrine Hcl 10 mg per ml | as per specs | 100 | nos | 18manish | 365 |
| 93 | Inj Pipracillin 4 gm with Tazobactum | as per specs | 92,000 | nos | 18manish | 365 |
| 94 | Inj Potassium Chloride 150 mg per 10 ml | as per specs | 85,000 | nos | 18manish | 365 |
| 95 | Inj Pralidoxime | as per specs | 1,000 | nos | 18manish | 365 |
| 96 | Inj Promethazine Hcl 25 ml | as per specs | 6,000 | nos | 18manish | 365 |
| 97 | Inj Propofol 1 percent | as per specs | 20,000 | nos | 18manish | 365 |
| 98 | Inj Ranitidine 25 mg per ml | as per specs | 15,000 | nos | 18manish | 365 |
| 99 | Inj Rocuronium Bromide 10 mg per ml | as per specs | 2,500 | nos | 18manish | 365 |
| 100 | Inj Sodabicarb 7.5 percent | as per specs | 130,000 | nos | 18manish | 365 |
| 101 | Inj Sodium Valporate 100 mg per 5 ml | as per specs | 10,000 | nos | 18manish | 365 |
| 102 | Inj Thiopentone Sodium 1 gm Vial | as per specs | 500 | nos | 18manish | 365 |
| 103 | Inj Tiecoplanin 400 mg Vial | as per specs | 8,000 | nos | 18manish | 365 |
| 104 | Inj Tiecoplanin 200 mg per 3 ml Vial | as per specs | 1,500 | nos | 18manish | 365 |
| 105 | Inj Tigecycline 50 mg Vial | as per specs | 8,000 | nos | 18manish | 365 |
| 106 | Inj Tranexanic Acid 100 mg per ml | as per specs | 30,000 | nos | 18manish | 365 |
| 107 | Inj Thiamine 100 mg per 2 ml | as per specs | 30,000 | nos | 18manish | 365 |
| 108 | Inj Vacuronium Bromide 4 mg per 2 ml | as per specs | 60,000 | nos | 18manish | 365 |
| 109 | Inj Vasopressin 20 IU Amp. | as per specs | 6,000 | nos | 18manish | 365 |
| 110 | Inj Vancomycin 500 mg Vial | as per specs | 90,000 | nos | 18manish | 365 |
Discover companies most likely to bid on this tender
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Extended Deadline
02-Jun-2025, 3:00 pm
Opening Date
02-Jun-2025, 3:30 pm
Extended Deadline
29-May-2025, 3:00 pm
Opening Date
29-May-2025, 3:30 pm
Extended Deadline
29-May-2025, 9:00 am
Opening Date
29-May-2025, 9:30 am
Extended Deadline
22-May-2025, 4:00 pm
Opening Date
22-May-2025, 4:30 pm
Start
02-Nov-2025, 4:00 pm
End
06-Nov-2025, 11:00 am
Duration: 91 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 22-05-2025 15:12:27 | Evaluated |
| 2 | ********** Under PMA | - | 19-05-2025 18:22:56 | Evaluated |
| 3 | ********** Under PMA | - | 21-05-2025 19:35:36 | Evaluated |
| 4 | ********** Under PMA | - | 21-05-2025 19:56:15 | Evaluated |
| 5 | ********** Under PMA | - | 21-05-2025 18:47:49 | Evaluated |
| 6 | ********** Under PMA | - | 29-05-2025 11:48:16 | Evaluated |
| 7 | ********** Under PMA | - | 21-05-2025 15:57:22 | Evaluated |
| 8 | ********** Under PMA | - | 02-05-2025 12:41:17 | Evaluated |
| 9 | ********** Under PMA | - | 22-05-2025 14:50:33 | Evaluated |
| 10 | ********** Under PMA | - | 21-05-2025 15:43:47 | Evaluated |
| 11 | ********** Under PMA | - | 29-04-2025 14:30:29 | Evaluated |
| 12 | ********** Under PMA | - | 17-05-2025 15:23:27 | Evaluated |
| 13 | ********** Under PMA | - | 21-05-2025 18:13:25 | Evaluated |
| 14 | ********** Under PMA | - | 16-05-2025 16:18:17 | Evaluated |
| 15 | ********** Under PMA | - | 22-05-2025 12:34:16 | Evaluated |
| 16 | ********** Under PMA | - | 19-05-2025 17:18:35 | Evaluated |
| 17 | ********** Under PMA | - | 29-04-2025 17:35:10 | Evaluated |
| 18 | ********** Under PMA | - | 02-05-2025 12:36:03 | Evaluated |
| 19 | ********** Under PMA | - | 22-05-2025 10:51:10 | Evaluated |
| 20 | ********** Under PMA | - | 21-04-2025 02:26:32 | Evaluated |
| 21 | ********** Under PMA | - | 22-05-2025 15:53:08 | Evaluated |
| 22 | ********** Under PMA | - | 02-05-2025 14:40:03 | Evaluated |
| 23 | ********** Under PMA | - | 31-05-2025 19:12:54 | Evaluated |
| 24 | ********** Under PMA | - | 22-05-2025 15:02:12 | Evaluated |
| 25 | ********** Under PMA | - | 01-05-2025 18:26:13 | Evaluated |
| 26 | ********** Under PMA | - | 01-05-2025 19:38:10 | Evaluated |
| 27 | ********** Under PMA | - | 25-04-2025 18:28:50 | Evaluated |
| 28 | ********** Under PMA | - | 22-05-2025 13:09:42 | Evaluated |
| 29 | ********** Under PMA | - | 26-04-2025 16:39:16 | Evaluated |
| 30 | ********** Under PMA | - | 20-05-2025 16:08:18 | Evaluated |
| 31 | ********** Under PMA | - | 09-05-2025 12:05:16 | Evaluated |
| 32 | ********** Under PMA | - | 02-05-2025 13:52:11 | Evaluated |
| 33 | ********** Under PMA | - | 02-05-2025 15:54:01 | Evaluated |
| 34 | ********** Under PMA | - | 21-05-2025 19:35:02 | Evaluated |
| 35 | ********** Under PMA | - | 20-05-2025 16:28:49 | Evaluated |
| 36 | ********** Under PMA | - | 28-05-2025 15:45:50 | Evaluated |
| 37 | ********** Under PMA | - | 22-05-2025 15:46:31 | Evaluated |
| 38 | ********** Under PMA | - | 02-05-2025 15:19:56 | Evaluated |
| 39 | ********** Under PMA | - | 21-05-2025 18:04:11 | Evaluated |
| 40 | ********** Under PMA | - | 30-04-2025 14:34:16 | Evaluated |
| 41 | ********** Under PMA | - | 24-04-2025 13:46:58 | Evaluated |
| 42 | ********** Under PMA | - | 22-05-2025 15:49:09 | Evaluated |
| 43 | ********** Under PMA | - | 22-05-2025 15:28:48 | Evaluated |
| 44 | ********** Under PMA | - | 02-05-2025 15:52:56 | Evaluated |
| 45 | ********** Under PMA | - | 29-04-2025 17:26:55 | Evaluated |
| 46 | ********** Under PMA | - | 02-05-2025 12:57:10 | Evaluated |
| 47 | ********** Under PMA | - | 21-05-2025 13:47:47 | Evaluated |
| 48 | ********** Under PMA | - | 21-05-2025 15:16:22 | Evaluated |
| 49 | ********** Under PMA | - | 02-05-2025 13:40:27 | Evaluated |
| 50 | ********** Under PMA | - | 19-04-2025 12:24:39 | Evaluated |
| 51 | ********** Under PMA | - | 02-05-2025 16:04:04 | Evaluated |
| 52 | ********** Under PMA | - | 02-05-2025 15:35:32 | Evaluated |
| 53 | ********** Under PMA | - | 22-05-2025 14:51:04 | Evaluated |
| 54 | ********** Under PMA | - | 01-05-2025 12:07:49 | Evaluated |
| 55 | ********** Under PMA | - | 14-05-2025 18:21:19 | Evaluated |
| 56 | ********** Under PMA | - | 21-05-2025 16:59:22 | Evaluated |
| 57 | ********** Under PMA | - | 01-05-2025 10:31:58 | Evaluated |
| 58 | ********** Under PMA | - | 21-05-2025 18:05:51 | Evaluated |
Key insights about DELHI tender market
The eligibility requirements include that bidders must be a registered entity certified to supply pharmaceutical products. They must adhere to compliance with relevant regulations set forth by the Ministry of Health and Family Welfare and have a proven track record of successful deliveries of injectable products. Suppliers need to provide valid registration certificates and a history of satisfactory performance in similar contracts.
Bidders must submit essential certificates that include their registration with drug regulatory authorities, Good Manufacturing Practices (GMP) certifications, and any other applicable quality assurance certifications. Compliance with local regulations and the Make in India initiative is also necessary, particularly for companies sourcing materials or manufacturing locally.
The registration process involves submitting requisite documentation electronically, including company registration, corporate financial documents, and details regarding previous experience with injection supplies. Bidders must also register on the GEM (Government e-Marketplace) portal if not already registered and comply with specific documentation requirements set by the Department.
Document submissions must adhere to specified accepted document formats, typically including PDF and Word formats, as outlined in the tender documentation. It is crucial that files are appropriately labeled and submitted through the indicated electronic platforms without any password protection to ensure accessibility for review.
The evaluation and selection process will consider both technical qualifications and pricing. Each bid will undergo rigorous scrutiny to assess compliance with the technical standards outlined in the tender. Bidders will be ranked based on comprehensive criteria, including quality, capability for large volume supplies, and overall pricing, ensuring a fair and transparent selection process.
Sign up now to access all documents
Main Document
BOQ
BOQ
OTHER
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS